WO2002002172A1 - Dna palindrome - oligoguanylic acid compositions and uses thereof - Google Patents

Dna palindrome - oligoguanylic acid compositions and uses thereof Download PDF

Info

Publication number
WO2002002172A1
WO2002002172A1 PCT/US2001/020443 US0120443W WO0202172A1 WO 2002002172 A1 WO2002002172 A1 WO 2002002172A1 US 0120443 W US0120443 W US 0120443W WO 0202172 A1 WO0202172 A1 WO 0202172A1
Authority
WO
WIPO (PCT)
Prior art keywords
oligoguanylic
uses
acid compositions
dna palindrome
palindrome
Prior art date
Application number
PCT/US2001/020443
Other languages
French (fr)
Other versions
WO2002002172A3 (en
WO2002002172A9 (en
Inventor
Hideko Kaji
Akira Kaji
Saburo Yamamoto
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US21547500P priority Critical
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of WO2002002172A1 publication Critical patent/WO2002002172A1/en
Publication of WO2002002172A9 publication Critical patent/WO2002002172A9/en
Publication of WO2002002172A3 publication Critical patent/WO2002002172A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • A61B17/425Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/43Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for artificial insemination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00Instruments or methods for reproduction or fertilisation
    • A61D19/02Instruments or methods for reproduction or fertilisation for artificial insemination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes

Abstract

The present invention provides an oligonucleotide for stimulating an immune response in a mammal. The oligonucleotides of the invention are palindromic and flanked by up to 11 guanylic acid residues. The immune response is stimulated by administering the oligonucleotides of the invention and inducing the secretion of cytokines.
PCT/US2001/020443 2000-06-30 2001-06-27 Dna palindrome - oligoguanylic acid compositions and uses thereof WO2002002172A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US21547500P true 2000-06-30 2000-06-30

Publications (3)

Publication Number Publication Date
WO2002002172A1 true WO2002002172A1 (en) 2002-01-10
WO2002002172A9 WO2002002172A9 (en) 2002-07-18
WO2002002172A3 WO2002002172A3 (en) 2002-10-10

Family

ID=22803128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020443 WO2002002172A1 (en) 2000-06-30 2001-06-27 Dna palindrome - oligoguanylic acid compositions and uses thereof

Country Status (1)

Country Link
WO (1) WO2002002172A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718623B2 (en) * 2004-02-27 2010-05-18 Emori & Co., Ltd. Immunostimulatory oligonucleotide that induces interferon alpha

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0468520A2 (en) * 1990-07-27 1992-01-29 MITSUI TOATSU CHEMICALS, Inc. Immunostimulatory remedies containing palindromic DNA sequences
WO1994008053A1 (en) * 1992-09-29 1994-04-14 Isis Pharmaceuticals, Inc. Oligonucleotides having a conserved g4 core sequence
WO1998016247A1 (en) * 1996-10-11 1998-04-23 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
WO1998018810A1 (en) * 1996-10-30 1998-05-07 The University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
WO1998037919A1 (en) * 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
WO1998052581A1 (en) * 1997-05-20 1998-11-26 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
WO1999058118A2 (en) * 1998-05-14 1999-11-18 Cpg Immunopharmaceuticals Gmbh METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0468520A2 (en) * 1990-07-27 1992-01-29 MITSUI TOATSU CHEMICALS, Inc. Immunostimulatory remedies containing palindromic DNA sequences
WO1994008053A1 (en) * 1992-09-29 1994-04-14 Isis Pharmaceuticals, Inc. Oligonucleotides having a conserved g4 core sequence
WO1998016247A1 (en) * 1996-10-11 1998-04-23 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
WO1998018810A1 (en) * 1996-10-30 1998-05-07 The University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
WO1998037919A1 (en) * 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
WO1998052581A1 (en) * 1997-05-20 1998-11-26 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
WO1999058118A2 (en) * 1998-05-14 1999-11-18 Cpg Immunopharmaceuticals Gmbh METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 148, no. 12, 15 June 1992 (1992-06-15), pages 4072 - 4076, XP002098020, ISSN: 0022-1767 *
SONEHARA K ET AL: "HEXAMER PALINDROMIC OLIGONUCLEOTIDES WITH 5'-CG-3' MOTIF(S) INDUCE PRODUCTION OF INTERFERON", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 16, no. 10, October 1996 (1996-10-01), pages 799 - 803, XP000863569, ISSN: 1079-9907 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718623B2 (en) * 2004-02-27 2010-05-18 Emori & Co., Ltd. Immunostimulatory oligonucleotide that induces interferon alpha

Also Published As

Publication number Publication date
WO2002002172A3 (en) 2002-10-10
WO2002002172A9 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
KR100991644B1 (en) Combination Motif Immune Stimulatory Oligonucleotides with Improved Activity
US7566703B2 (en) Semi-soft C-class immunostimulatory oligonucleotides
AU2004285561B2 (en) C-class oligonucleotide analogs with enhanced immunostimulatory potency
KR101126030B1 (en) Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
ES2634328T3 (en) Immunostimulatory Nucleic Acids
TWI243819B (en) Imidazopyridines derivatives useful as immune response modifiers
EP1350262B8 (en) Cpg-like nucleic acids and methods of use thereof
CA2177732A1 (en) Antisense oligonucleotides having tumorigenicity-inhibiting activity
PT776376E (en) Using arn-polymerase to improve the amplification process of nucleic acid
UA70914C2 (en) Formula of polynucleotide vaccine against respiratory pathogens of the cattle
EP2261235A3 (en) Inhibitors of caspases
CA2338504A1 (en) Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
AU6667498A (en) Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders
WO2002036743A3 (en) Antisense modulation of calreticulin expression
EP2253706A3 (en) Antisense modulation of kinesin-like 1 expression
AU8429501A (en) Method of sequencing dna
AU5736601A (en) Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
AU2897402A (en) Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
ZA200102420B (en) Methods of nucleic acid amplification and sequencing.
AU9096501A (en) Target activated nucleic acid biosensor and methods of using same
CA2445046A1 (en) Nitrilases
NZ525321A (en) Adjuvant formulations comprising an immunostimulatory oligonucleotide (DNA) and a tocol
EP2298811A3 (en) Human anti-ifn-gamma neutralizing antibodies as selective ifn-gamma pathway inhibitors
WO2003099195A3 (en) Immunomodulatory compounds and methods of use thereof
AU9084601A (en) G-csf analog compositions and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

COP Corrected version of pamphlet

Free format text: PUBLISHED INTERNATIONAL SEARCH REPORT DELETED (2 PAGES) (WITH AN UPDATED VERSION OF THE FRONT PAGE)

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP